Delphi Panel on the Relationship Between Long-Acting Injectable Antipsychotics and Longer-Term Functional Recovery in First-Episode and Early-Phase Schizophrenia Patients

被引:0
|
作者
Kane, John M. [1 ]
Yildirim, Murat [2 ]
Madera-McDonough, Jessica [3 ]
Arango, Celso [4 ]
Fagiolini, Andrea [5 ]
Gorwood, Philip [6 ]
Sahota, Navdeep [7 ]
Correll, Christoph U. [8 ]
机构
[1] Northwell Hlth, Feinstein Inst Med Res, Inst Behav Sci, New York, NY USA
[2] H Lundbeck & Co AS, Copenhagen, Denmark
[3] Otsuka Pharmaceut Co Ltd, Tokyo, Japan
[4] Hosp Gen Univ Gregorio Maranon, Child & Adolescent Dept Psychiat, Madrid, Spain
[5] Univ Siena, Div Psychiat, Siena, Italy
[6] Univ Paris, Inst Psychiat & Neurosci Paris, Paris, France
[7] OPEN Hlth, London, England
[8] Hofstra Northwell Hempstead, Donald & Barbara Zucker Sch Med, Dept Psychiat & Mol Med, New York, NY USA
关键词
D O I
10.1017/S1092852923001931
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:253 / 253
页数:1
相关论文
共 50 条
  • [1] Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery
    Arango, Celso
    Fagiolini, Andrea
    Gorwood, Philip
    Kane, John M.
    Diaz-Mendoza, Sergio
    Sahota, Navdeep
    Correll, Christoph U.
    BMC PSYCHIATRY, 2023, 23 (01)
  • [2] Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery
    Celso Arango
    Andrea Fagiolini
    Philip Gorwood
    John M. Kane
    Sergio Diaz-Mendoza
    Navdeep Sahota
    Christoph U. Correll
    BMC Psychiatry, 23
  • [3] Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
    Parellada, Eduard
    Velligan, Dawn I.
    Emsley, Robin
    Kissling, Werner
    SCHIZOPHRENIA RESEARCH AND TREATMENT, 2012, 2012
  • [4] Long-acting Injectable Antipsychotics in First-episode Schizophrenia
    Jeong, Hyun Ghang
    Lee, Moon Soo
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2013, 11 (01) : 1 - 6
  • [5] Delphi Panel on the Dimensions and Assessment of Functional Recovery in First-Episode and Early-Phase Schizophrenia Patients
    Kane, John M.
    Yildirim, Murat
    Madera-McDonough, Jessica
    Arango, Celso
    Fagiolini, Andrea
    Gorwood, Philip
    Sahota, Navdeep
    Correll, Christoph U.
    CNS SPECTRUMS, 2023, 28 (02) : 251 - 252
  • [6] Guidelines on long-acting injectable atypical antipsychotics for first-episode schizophrenia
    Azorin, J. -M.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2013, 39 : S121 - S123
  • [7] Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia: The Pros and Cons
    Kim, Borah
    Lee, Sang-Hyuk
    Yang, Yen Kuang
    Park, Jong-Il
    Chung, Young-Chul
    SCHIZOPHRENIA RESEARCH AND TREATMENT, 2012, 2012
  • [8] LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN FIRST EPISODE SCHIZOPHRENIA
    Fleischhacker, Wolfgang
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S312 - S312
  • [9] Applying Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia to Achieve First Remission
    Chen-Chung Liu
    Huey-Ling Chiang
    Szu-Ying Wu
    CNS Drugs, 2008, 22 : 257 - 258
  • [10] Applying long-acting injectable antipsychotics in first-episode schizophrenia to achieve first remission
    Liu, Chen-Chung
    Chiang, Huey-Ling
    Wu, Szu-Ying
    CNS DRUGS, 2008, 22 (03) : 257 - 258